サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1530410

女性不妊診断の市場規模、シェア、動向分析レポート：検査別、地域別、セグメント予測、2024年～2030年

Female Infertility Diagnosis Market Size, Share & Trends Analysis Report By Test (Ovarian Reserve Testing, Hormone Testing, Hysterosalpingography, Other Tests), By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 90 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
女性不妊診断の市場規模、シェア、動向分析レポート：検査別、地域別、セグメント予測、2024年～2030年
出版日: 2024年07月23日
発行: Grand View Research
ページ情報: 英文 90 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

女性不妊診断市場動向

世界の女性不妊診断市場規模は、2023年に44億5,000万米ドルと推定され、2024年から2030年にかけてCAGR 8.6％で成長すると予測されています。同市場の成長を牽引しているのは、不妊症の増加や多嚢胞性卵巣症候群（PCOS）などの疾患の蔓延に寄与しているライフスタイルの変化です。2023年6月に発表された世界保健機関（WHO）の報告書によると、PCOSは生殖年齢にある女性の約8～13％が罹患しており、罹患者の最大70％は世界的に診断されていないです。

例えば、2022年6月にJournal of Korean Medical Science誌に掲載された研究によると、韓国は過去30年間で、OECD加盟国の中で最も出生率が低下しています。韓国政府はこの動向を踏まえ、健康的な妊娠・出産を促進することの重要性を認識し、2021年に開始された「第4次少子高齢社会基本計画」などの取り組みを通じて、少子化対策や母体年齢の高い妊娠を支援することを目的とした政策を導入しています。その結果、少子化は不妊診断や生殖補助医療技術の需要を押し上げ、市場成長の拡大につながると予想されます。

生活習慣は男女ともに不妊に大きな影響を与えます。喫煙、過度の飲酒、食生活の乱れ、座りがちな生活習慣などの要因は、生殖機能に悪影響を及ぼす可能性があります。さらに、これらの生活習慣は、ホルモンバランスの乱れ、酸化ストレス、炎症、生殖機能の低下など、様々なメカニズムを通じて生殖能力に影響を及ぼす可能性があります。WHOによると、不妊症の有病率は低・中所得国で16.5%、高所得国では17.8%です。

女性不妊症診断の世界市場セグメンテーションレポート

本レポートでは、2018年から2030年にかけての収益成長を国レベルで予測し、各サブセグメントにおける最新の業界動向と収益機会に関する分析を提供しています。この調査において、Grand View Research社は女性不妊診断市場レポートを検査と地域に基づいてセグメント化しています：

  • 検査の展望（売上高、2018年～2030年）。
  • 卵巣予備能検査。
  • 子宮卵管造影検査。
  • ホルモン検査。
  • その他の検査。
  • 地域の展望（収入、2018年～2030年）。
  • 北米。

米国。

カナダ

メキシコ

  • 欧州

英国

ドイツ

フランス

イタリア

スペイン

デンマーク

スウェーデン

ノルウェー

  • アジア太平洋

日本

中国

インド

オーストラリア

韓国

タイ

  • ラテンアメリカ

ブラジル

アルゼンチン

  • 中東＆アフリカ

南アフリカ

サウジアラビア

アラブ首長国連邦

クウェート

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 女性不妊診断市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場 促進要因分析
    • 市場抑制要因分析
  • 女性不妊診断市場分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析

第4章 女性不妊診断市場：検査の推定・動向分析

  • セグメントダッシュボード
  • 女性不妊診断市場：テスト変動分析
  • 女性不妊診断市場：検査別展望
  • 卵巣予備能検査
  • 子宮卵管造影検査
  • ホルモン検査
  • その他のテスト

第5章 女性不妊診断市場：地域推定・動向分析

  • 地域ダッシュボード
  • 地域別女性不妊診断市場：重要なポイント
  • 北米
    • 北米女性不妊診断市場推計・予測、2018年-2030年
    • 米国
    • カナダ
    • メキシコ
    • 欧州
    • 欧州における女性不妊症診断市場推計・予測、2018年-2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • アジア太平洋の女性不妊診断市場推計・予測、2018年-2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ラテンアメリカの女性不妊診断市場推計・予測、2018年-2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカの女性不妊診断市場推計・予測、2018年-2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 市場参入企業の分類
  • 企業の市況分析
  • 主要企業プロファイル
    • PFCLA
    • Mayo Foundation for Medical Education and Research（MFMER）
    • Cleveland Clinic
    • Apricity Fertility UK Limited
    • King's Fertility Limited
    • Dallas IVF
    • Midwest Fertility Specialists
    • Europe IVF
    • Care Fertility
    • Aspire Fertility
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 4 North America Female Infertility Diagnosis market, by region, 2018 - 2030 (USD Million)
  • Table 5 North America Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 6 U.S. Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 7 Canada Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 8 Mexico Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 9 Europe Female Infertility Diagnosis market, by country, 2018 - 2030 (USD Million)
  • Table 10 Europe Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 11 UK Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 12 Germany Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 13 France Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 14 Italy Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 15 Spain Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 16 Norway Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 17 Sweden Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 18 Denmark Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 19 Asia Pacific Female Infertility Diagnosis market, by country, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 21 Japan Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 22 China Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 23 India Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 24 Australia Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 25 South Korea Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 26 Thailand Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 27 Latin America Female Infertility Diagnosis market, by country, 2018 - 2030 (USD Million)
  • Table 28 Latin America Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 29 Brazil Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 30 Argentina Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 31 Middle East & Africa Female Infertility Diagnosis market, by country, 2018 - 2030 (USD Million)
  • Table 32 Middle East & Africa Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 33 South Africa Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 34 Saudi Arabia Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 35 UAE Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 36 Kuwait Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)

List of Figures

  • Fig 1. Information Procurement
  • Fig 2. Primary Research Pattern
  • Fig 3. Market Research Approaches
  • Fig 4. Value Chain-Based Sizing & Forecasting
  • Fig 5. Market Formulation & Validation
  • Fig 6. Female infertility diagnosis market segmentation
  • Fig 7. Market driver analysis (Current & future impact)
  • Fig 8. Market restraint analysis (Current & future impact)
  • Fig 9. Porter's Five Forces Analysis
  • Fig 10. PESTEL Analysis
  • Fig 11. Female infertility diagnosis market: Tests segment dashboard
  • Fig 12. Female infertility diagnosis market: Tests movement analysis, 2023 & 2030
  • Fig 13. Ovarian reserve testing products market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 14. Hysterosalpingography market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 15. Hormone testing market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 16. Other tests market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 17. Female infertility diagnosis market: Regional key takeaways (USD Million)
  • Fig 18. Female infertility diagnosis market regional outlook, 2023 & 2030, (USD Million)
  • Fig 19. North America female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 20. U.S. female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 21. Canada female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 22. Mexico female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 23. Europe female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 24. UK female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 25. Germany female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 26. France female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 27. Spain female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 28. Italy female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 29. Sweden female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 30. Norway female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 31. Denmark female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 32. Asia Pacific female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 33. China female infertility diagnosis estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 34. Japan female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 35. India female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 36. South Korea female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 37. Australia female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 38. Thailand female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 39. Latin America female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 40. Brazil female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 41. Argentina female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 42. Middle East and Africa female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 43. South Africa female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 44. Saudi Arabia female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 45. UAE female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 46. Kuwait female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-369-6

Female Infertility Diagnosis Market Trends

The global female infertility diagnosis market size was estimated at USD 4.45 billion in 2023 and is projected to grow at a CAGR of 8.6% from 2024 to 2030. The market's growth is driven by the growing changes in lifestyle, which contribute to the rise in infertility and the prevalence of conditions such as polycystic ovary syndrome (PCOS). According to a World Health Organization (WHO) report published in June 2023, PCOS affects approximately 8-13% of women of reproductive age, with up to 70% of those affected going undiagnosed globally.

Additionally, a constant increase in the incidence of infertility in both sexes is projected to drive the market.For instance, according to a study published in Journal of Korean Medical Science, in June 2022, South Korea has experienced the most significant decline in fertility rates among all OECD countries in the last three decades. The Korean government has acknowledged the importance of promoting healthy pregnancies and childbirth considering this trend and has introduced policies aimed at addressing the low fertility rate and supporting advanced maternal age pregnancies through initiatives such as 'The Fourth Basic Plan on Low Fertility and Aging Society' launched in 2021. Consequently, the low fertility rate is expected to drive up the demand for infertility diagnosis and assisted reproductive technologies, leading to an expansion in the market growth.

The lifestyle habits play a significant role in influencing fertility in both men and women. Factors such as smoking, excessive alcohol consumption, poor diet, and sedentary habits can have detrimental effects on reproductive health. In addition, these lifestyle habits can impact fertility through various mechanisms, including hormonal imbalances, oxidative stress, inflammation, and impaired reproductive function. According to WHO, prevalence of infertility is 16.5% in low & middle income countries and 17.8% in high income countries.

Global Female Infertility Diagnosis Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the female infertility diagnosis market report based on test and region:

  • Test Outlook (Revenue, USD Million, 2018 - 2030)
  • Ovarian Reserve Testing
  • Hysterosalpingography
  • Hormone testing
  • Other Tests
  • Region Outlook (Revenue, USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

  • Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

  • Latin America

Brazil

Argentina

  • Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Tests
      • 1.1.1.2. Regional scope
    • 1.1.2. Estimates and forecasts timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.1.3. Purchased database
    • 1.1.4. GVR's internal database
    • 1.1.5. Secondary sources
    • 1.1.6. Primary research
    • 1.1.7. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.1.8. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.1.9. Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Female Infertility Diagnosis Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Female Infertility Diagnosis Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis

Chapter 4. Female Infertility Diagnosis Market: Tests Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Female Infertility Diagnosis Market: Tests Movement Analysis
  • 4.3. Female Infertility Diagnosis Market by Tests Outlook (USD Million)
  • 4.4. Ovarian Reserve Testing
    • 4.4.1. Ovarian Reserve Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Hysterosalpingography
    • 4.5.1. Hysterosalpingography Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Hormone Testing
    • 4.6.1. Hormone Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Other Tests
    • 4.7.1. Other Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Female Infertility Diagnosis Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Dashboard
  • 5.2. Regional Female Infertility Diagnosis Market: Key Takeaways
  • 5.3. North America
    • 5.3.1. North America Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Key Country Dynamics
      • 5.3.2.2. Competitive Scenario
      • 5.3.2.3. Regulatory Framework
      • 5.3.2.4. Reimbursement scenario
      • 5.3.2.5. U.S. Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Key Country Dynamics
      • 5.3.3.2. Competitive Scenario
      • 5.3.3.3. Regulatory Framework
      • 5.3.3.4. Reimbursement scenario
      • 5.3.3.5. Canada Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Mexico
      • 5.3.4.1. Key Country Dynamics
      • 5.3.4.2. Competitive Scenario
      • 5.3.4.3. Regulatory Framework
      • 5.3.4.4. Reimbursement scenario
      • 5.3.4.5. Mexico Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.5. Europe
    • 5.3.6. Europe Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.7. UK
      • 5.3.7.1. Key Country Dynamics
      • 5.3.7.2. Competitive Scenario
      • 5.3.7.3. Regulatory Framework
      • 5.3.7.4. Reimbursement scenario
      • 5.3.7.5. UK Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.8. Germany
      • 5.3.8.1. Key Country Dynamics
      • 5.3.8.2. Competitive Scenario
      • 5.3.8.3. Regulatory Framework
      • 5.3.8.4. Reimbursement scenario
      • 5.3.8.5. Germany Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.9. France
      • 5.3.9.1. Key Country Dynamics
      • 5.3.9.2. Competitive Scenario
      • 5.3.9.3. Regulatory Framework
      • 5.3.9.4. Reimbursement scenario
      • 5.3.9.5. France Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.10. Italy
      • 5.3.10.1. Key Country Dynamics
      • 5.3.10.2. Competitive Scenario
      • 5.3.10.3. Regulatory Framework
      • 5.3.10.4. Reimbursement scenario
      • 5.3.10.5. Italy Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.11. Spain
      • 5.3.11.1. Key Country Dynamics
      • 5.3.11.2. Competitive Scenario
      • 5.3.11.3. Regulatory Framework
      • 5.3.11.4. Reimbursement scenario
      • 5.3.11.5. Spain Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.12. Denmark
      • 5.3.12.1. Key Country Dynamics
      • 5.3.12.2. Competitive Scenario
      • 5.3.12.3. Regulatory Framework
      • 5.3.12.4. Reimbursement scenario
      • 5.3.12.5. Denmark Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.13. Sweden
      • 5.3.13.1. Key Country Dynamics
      • 5.3.13.2. Competitive Scenario
      • 5.3.13.3. Regulatory Framework
      • 5.3.13.4. Reimbursement scenario
      • 5.3.13.5. Sweden Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.14. Norway
      • 5.3.14.1. Key Country Dynamics
      • 5.3.14.2. Competitive Scenario
      • 5.3.14.3. Regulatory Framework
      • 5.3.14.4. Reimbursement scenario
      • 5.3.14.5. Norway Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Japan
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Competitive Scenario
      • 5.4.2.3. Regulatory Framework
      • 5.4.2.4. Reimbursement scenario
      • 5.4.2.5. Japan Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. China
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Competitive Scenario
      • 5.4.3.3. Regulatory Framework
      • 5.4.3.4. Reimbursement scenario
      • 5.4.3.5. China Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. India
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Competitive Scenario
      • 5.4.4.3. Regulatory Framework
      • 5.4.4.4. Reimbursement scenario
      • 5.4.4.5. India Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.5. South Korea
      • 5.4.5.1. Key Country Dynamics
      • 5.4.5.2. Competitive Scenario
      • 5.4.5.3. Regulatory Framework
      • 5.4.5.4. Reimbursement scenario
      • 5.4.5.5. South Korea Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.6. Australia
      • 5.4.6.1. Key Country Dynamics
      • 5.4.6.2. Competitive Scenario
      • 5.4.6.3. Regulatory Framework
      • 5.4.6.4. Reimbursement scenario
      • 5.4.6.5. Australia Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.7. Thailand
      • 5.4.7.1. Key Country Dynamics
      • 5.4.7.2. Competitive Scenario
      • 5.4.7.3. Regulatory Framework
      • 5.4.7.4. Reimbursement scenario
      • 5.4.7.5. Thailand Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Latin America
    • 5.5.1. Latin America Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. Brazil
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Competitive Scenario
      • 5.5.2.3. Regulatory Framework
      • 5.5.2.4. Reimbursement scenario
      • 5.5.2.5. Brazil Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Argentina
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Competitive Scenario
      • 5.5.3.3. Regulatory Framework
      • 5.5.3.4. Reimbursement scenario
      • 5.5.3.5. Argentina Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Middle East & Africa
    • 5.6.1. Middle East & Africa Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. South Africa
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Competitive Scenario
      • 5.6.2.3. Regulatory Framework
      • 5.6.2.4. Reimbursement scenario
      • 5.6.2.5. South Africa Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. Saudi Arabia
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Competitive Scenario
      • 5.6.3.3. Regulatory Framework
      • 5.6.3.4. Reimbursement scenario
      • 5.6.3.5. Saudi Arabia Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.4. UAE
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Competitive Scenario
      • 5.6.4.3. Regulatory Framework
      • 5.6.4.4. Reimbursement scenario
      • 5.6.4.5. UAE Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.5. Kuwait
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Competitive Scenario
      • 5.6.5.3. Regulatory Framework
      • 5.6.5.4. Reimbursement scenario
      • 5.6.5.5. Kuwait Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Market Participant Categorization
  • 6.2. Company Market Position Analysis
  • 6.3. Key Company Profiles
    • 6.3.1. PFCLA
      • 6.3.1.1. Company overview
      • 6.3.1.2. Financial performance
      • 6.3.1.3. Service benchmarking
      • 6.3.1.4. Strategic initiatives
    • 6.3.2. Mayo Foundation for Medical Education and Research (MFMER)
      • 6.3.2.1. Company overview
      • 6.3.2.2. Financial performance
      • 6.3.2.3. Service benchmarking
      • 6.3.2.4. Strategic initiatives
    • 6.3.3. Cleveland Clinic
      • 6.3.3.1. Company overview
      • 6.3.3.2. Financial performance
      • 6.3.3.3. Service benchmarking
      • 6.3.3.4. Strategic initiatives
    • 6.3.4. Apricity Fertility UK Limited
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Service benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. King's Fertility Limited
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Service benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Dallas IVF
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Service benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Midwest Fertility Specialists
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Service benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. Europe IVF
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Service benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. Care Fertility
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Service benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Aspire Fertility
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Service benchmarking
      • 6.3.10.4. Strategic initiatives